What it is
Zoledronic acid, sold as Reclast in the United States, is a bisphosphonate given as an intravenous infusion rather than a tablet. For osteoporosis treatment it is given once a year; for prevention, once every two years. The infusion itself takes at least fifteen minutes.
Why some women prefer it to tablets
Oral bisphosphonates are poorly absorbed and demanding to take correctly: on an empty stomach, with plain water, staying upright and not eating for at least half an hour. Many women either cannot tolerate that or quietly stop. An annual infusion removes the adherence problem entirely and avoids upper gastrointestinal irritation.
It is also an option where swallowing is difficult or where reflux disease makes oral bisphosphonates unattractive.
The first infusion: what actually happens to most people
An acute phase reaction is common after the first dose and much less common after subsequent ones. It feels like a short bout of flu: fever, aching muscles and joints, headache, tiredness, usually starting within a day or two and settling within about three days.
It is not an allergy and it is not a sign the drug is wrong for you. Being well hydrated beforehand and taking acetaminophen around the infusion, if your clinician agrees it is appropriate for you, reduces it. Plan the infusion for a day when you can take it easy the next day rather than before something that matters.
What has to be checked first
- Kidney function. Zoledronic acid is not given below a defined creatinine clearance threshold, and dehydration at the time of infusion raises risk. Your prescriber will check this beforehand.
- Calcium and vitamin D. These must be adequate before the infusion. Low vitamin D increases the chance of hypocalcaemia afterwards.
- Dental work. As with all antiresorptives, planned extractions and implants are better completed before starting.
How long it continues
Because bisphosphonates bind to bone and keep working after the last dose, a planned pause is a reasonable discussion after roughly three annual infusions in women who are no longer at high risk. That decision depends on fracture history and density, not on the calendar alone — see our page on stopping osteoporosis medication.
Questions worth asking
- "What is my kidney function, and does it allow this?"
- "Are my vitamin D and calcium adequate before we infuse?"
- "What should I do the day of and the day after the first infusion?"
- "How many infusions before we reassess?"
The day itself
Drink well the day before and the morning of the infusion unless you have been told to restrict fluids. Eat normally. The infusion runs over at least fifteen minutes; the appointment itself is usually under an hour including checks.
Afterwards, keep drinking fluids and plan a quiet next day for the first infusion. Most women who have a reaction describe it as feeling like the start of flu for a day or two rather than anything alarming.
Zoledronic acid compared with oral bisphosphonates
| Annual infusion | Weekly tablet | |
|---|---|---|
| Dosing routine | Once a year, supervised | Weekly, empty stomach, stay upright 30 min |
| Upper gut side effects | Avoided | Common reason for stopping |
| Adherence problem | Removed | Substantial in practice |
| Acute phase reaction | Common after first dose | Not typical |
| Kidney restriction | Yes, checked each time | Yes |
Rare effects worth knowing by name
Osteonecrosis of the jaw and atypical femoral fracture are rare and associated with the antiresorptive class rather than this drug alone. Report persistent jaw pain or a dental socket that will not heal, and report new thigh or groin pain that builds over weeks rather than appearing suddenly.
Eye inflammation — pain, redness or blurred vision in the days after an infusion — is uncommon but is a reason to seek care promptly rather than wait.
Calcium and vitamin D are not optional extras
Zoledronic acid slows the removal of calcium from bone, and if dietary calcium and vitamin D are inadequate, blood calcium can fall. Getting these right before the infusion is part of the treatment, not a general wellness suggestion. Your prescriber will usually check vitamin D beforehand and correct a deficiency first.
After the first year
Bone density is normally repeated to confirm the treatment is doing what was intended. A stable or improving result is the expected outcome; a meaningful fall prompts a review of adherence, absorption, calcium and vitamin D status, and whether an underlying cause of bone loss has been missed.